Milestone Scientific Inc. Files Amendment No. 1 to Annual Report: Key Investor Insights

Overview

Milestone Scientific Inc. (NYSE American: MLSS) has filed Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This amendment, filed on May 5, 2026, is significant for shareholders and investors, as it addresses specific omissions and corrections to the original filing made on March 31, 2026.

Key Points in the Report

• Amendment Purpose: The amendment was filed to include the entire Restated Certificate of Incorporation as Exhibit 3.1 and to restore the Amended and Restated By-laws as Exhibit 3.2. The original Form 10-K had inadvertently omitted portions of these documents, which are critical corporate governance materials.
• No Financial Statement Changes: The amendment does not contain or amend any financial statements. It also does not impact disclosures related to internal controls or other financial matters.
• Certifications: New certifications by the principal executive officer (Eric Hines) and principal financial officer (Keisha Harcum) are included, as required by Section 302 of the Sarbanes-Oxley Act. These certifications confirm the accuracy and completeness of the amendment.
• Corporate Information:
  • Principal executive offices are now listed as 425 Eagle Rock Avenue, Roseland, NJ 07068, with phone number (973) 535-2717.
  • State of incorporation: Delaware; EIN: 13-3545623.
  • Common Stock, par value \$0.001 per share, trading symbol: MLSS, listed on NYSE American.
  • As of March 31, 2026, Milestone Scientific has 80,453,801 shares outstanding.
  • Aggregate market value held by non-affiliates as of June 30, 2025: \$39,730,497 (based on closing price \$0.64/share).
• SEC Filings Status: The company confirms it is a non-accelerated filer, a smaller reporting company, and not an emerging growth company. It is not a shell company.
• No Other Changes: The amendment does not update any other information from the original Form 10-K and does not reflect events after the original filing date.

Important Shareholder Considerations

• Corporate Governance Documents: The inclusion of the Restated Certificate of Incorporation and Amended/Restated By-laws is material for shareholders, as these documents set forth the company’s organizational structure, rights, and governance. Any changes or corrections to these documents could affect shareholder rights and the company’s operations.
• Potential Price Sensitivity: While this amendment is primarily administrative in nature, the correction and official filing of key governance documents may affect investor confidence, especially if prior omissions led to uncertainties about the company’s bylaws or corporate structure. The filing reconfirms the legal foundation of Milestone Scientific Inc.
• Management Certifications: The updated certifications from the CEO and Principal Accounting Officer may reassure investors regarding the accuracy and completeness of corporate filings.
• Market Value and Shares Outstanding: Investors should note the updated share count and public float, which are relevant for valuation and trading considerations, especially given the relatively low per-share price and market capitalization for a NYSE-listed entity.
• No Financial Statement Changes: There are no corrections or restatements of financial statements, which means the amendment does not impact earnings, revenue, or other financial metrics. However, the absence of financial corrections is itself a positive sign for regulatory compliance and operational stability.

Exhibits Filed with Amendment

• 3.1 – Restated Certificate of Incorporation of Milestone, as amended as of March 10, 2025
• 3.2 – Amended and Restated By-laws of Milestone Scientific Inc.
• 31.1 – Certification of Principal Executive Officer
• 31.2 – Certification of Principal Financial Officer
• 104 – Cover Page Interactive Data File (Inline XBRL)

Analysis for Investors

The filing of Amendment No. 1 is primarily an administrative correction. While it does not contain news on earnings, acquisitions, or material financial changes, the proper inclusion of fundamental corporate documents is essential for compliance, legal certainty, and investor relations. The amendment demonstrates management’s commitment to regulatory accuracy and transparency.

For investors, this action may modestly enhance confidence in the company’s governance practices, but is unlikely to significantly move the share price unless there were pre-existing concerns about omitted documents. The current market capitalization and share count are worth noting for trading and valuation purposes.

Conclusion

Shareholders should review the newly filed governance documents, as any material terms therein could impact future corporate actions, proxy voting, or shareholder rights. No financial or operational changes have been disclosed in this amendment.

Disclaimer: This article is based on the publicly filed Amendment No. 1 to Milestone Scientific Inc.’s Form 10-K for the fiscal year ended December 31, 2025. It is for informational purposes only and does not constitute investment advice. Investors are encouraged to review the full SEC filings and consult with financial advisors before making investment decisions.

View MILESTONE SCIENTIFIC INC. Historical chart here